Table 1.
STEMI | NSTEMI | UA | |||||||
---|---|---|---|---|---|---|---|---|---|
Time period | Mar-Apr 2019 | Mar-Apr 2020 | p value | Mar-Apr 2019 | Mar-Apr 2020 | p value | Mar-Apr 2019 | Mar-Apr 2020 | p value |
Number of admissions (n) | 49 | 46 | n.s | 95 | 50 | < 0.001 | 94 | 48 | < 0.001 |
Female gender | 26.5% (13/49) | 32.6% (15/46) | 0.52 | 27.4% (26/95) | 32.0% (16/50) | 0.56 | 38.3% (36/94) | 43.8% (21/48) | 0.53 |
Age (years. mean ± SD) | 65,9 ± 14,2 | 64,0 ± 13,8 | 0.67 | 70,5 ± 12,3 | 71,7 ± 12,1 | 0.58 | 68.8 ± 13.7 | 70.5 ± 10.8 | 0.58 |
CV risk factors | |||||||||
Art. hypertension | 83.7% (41/49) | 73.9% (34/46) | 0.24 | 77.9% (74/95) | 82.0% (41/50) | 0.56 | 83.0% (78/94) | 83.3% (40/48) | 0.96 |
Diabetes mellitus | 16.3% (8/49) | 34.8% (16/46) | < 0.05 | 33.7% (32/95) | 40.0% (20/50) | 0.45 | 29.8% (28/94) | 20.8% (10/48) | 0.25 |
Hyperlipidemia | 51.0% (25/49) | 65.2% (30/46) | 0.16 | 61.1% (58/95) | 74.0% (37/50) | 0.12 | 45.7% (43/94) | 66.7% (32/48) | < 0.05 |
Smoker (current) | 22.4% (11/49) | 15.2% (7/46) | 0.37 | 9.5% (9/95) | 6.0% (3/50) | 0.47 | 7.4% (7/94) | 10.4% (5/48) | 0.55 |
Comorbidities | 6.1% (3/49) | 2.2% (1/46) | 0.34 | 9.5% (9/95) | 6.0% (3/50) | 0.47 | 10.6% (10/94) | 12.5% (6/48) | 0.74 |
COPD | 0.0% (0/49) | 2.2% (1/46) | 0.30 | 17.9% (17/95) | 14.0% (7/50) | 0.55 | 6.4% (6/94) | 4.2% (2/48) | 0.59 |
Peripheral artery disease | 2.0% (1/49) | 0.0% (0/46) | 0.33 | 1.1% (1/95) | 2.0% (1/50) | 0.64 | 0.0% (0/94) | 0.0% (0/48) | n.a |
Prior stroke/TIA | 16.3% (8/49) | 13.0% (6/46) | 0.65 | 42.1% (40/95) | 36.0% (18/50) | 0.48 | 20.2% (19/94) | 18.8% (9/48) | 0.84 |
Renal failure | 6.1% (3/49) | 2.2% (1/46) | 0.34 | 9.5% (9/95) | 6.0% (3/50) | 0.47 | 10.6% (10/94) | 12.5% (6/48) | 0.74 |
Troponin I hs (ng/l)Median with interquartile range | n.a | n.a | n.a | 1179,0 (294,0; 5660,0) | 1501,0 (530,0; 8788,0) | 0.27 | n.a | n.a | n.a |
STEMI ST-elevation-myocardial-infarction, NSTEMI Non-ST-elevation-myocardial-infarction, UA unstable angina
Statistical Analysis: Continuous variables are presented as mean with standard deviation or median with interquartile range and compared with Mann–Whitney-Wilcoxon test. Categorical variables are presented as counts and percentages and compared with the Chi2-test. All tests were two-tailed and p values < 0.05 were considered statistically significant. Statistical analyses were performed with SAS statistical package, version 9.4 (SAS Institute)